Specialty and patient registries depend on retrospective abstraction, so completeness decays and outcomes after the visit go unrecorded. A Circle runs on a protocol your experts write, captures each answer inside the visit and from patients at home, and returns comparative measures to members as data arrives, as MOTIV™ does with OREF.
Each runs on the same four pillars: the Observational Protocol, the Circle, the closed system and the technical stack. The methodological detail sits in the linked white papers.
Set the protocol for your specialty or condition, from first symptom to long-term outcome, including care no billing code captures.
A Circle opens with one testable statement, and the society is the right body to write it. Authorizing the Observational Protocol makes the society the methodological authority for the specialty's evidence rather than a customer of a registry vendor. MOTIV™ is the working example: a national TKA Circle, authorized by OREF and open to participating sites.
Members answer through inCytes™ while the patient is in front of them, and patients report through Benchmarc™ whether or not they return.
Registry participation usually means re-entering data after clinic, which is why completeness falls away in later follow-up years. With capture in the encounter and at home, follow-up continues for the whole episode, and there is no abstraction workforce to fund.
When a Circles Dataset is licensed, most of the value is allocated under the Ownership Agreement, which can include a share for the convening society and the protocol’s authors.
For societies, that means the clinicians who captured and attested the data. For patient advocacy groups, it also means your members directly: every Circles Dataset traces back to patients who consented to its use, and Circle Health Coin lets each patient earn the value their own data creates, under terms a smart contract enforces automatically. The mechanics are detailed in the relevant white papers.
Guideline and policy questions answered on records traceable to their source; Medicare coverage registries; natural history that FDA now accepts as rare disease confirmatory evidence.
Guideline committees currently weigh trial data against registry data of uncertain provenance. Because each value carries its attesting clinician, credential and timestamp, and verification uses zero-knowledge proofs computed at the data source, a committee can test individual records instead of accepting an aggregate — the conditions the FDA's December 2025 guidance describes.
Comparative outcome reports, Circle Hours, co-authored publications and a share of license value, in place of an unpaid reporting duty.
Recruitment into registries stalls because the work sits with the clinician and the value sits with the vendor. On the Circles Platform participating members are Circle Members: they hold compilation ownership, their consented patients hold their own rights on Circle Health Coin, and licensing happens on the Circles Datasets Exchange with the proceeds flowing back to the Circle.
Sources: Mercuri and Wickline, JOEI (2026); Casalino et al., Health Affairs (2016); CMS Coverage with Evidence Development; NCATS Rare Diseases Fact Sheet.
It can, or it can run alongside it. A Circle does not import registry data; it records new episodes to your protocol, and each answer can carry your registry’s codes so results are comparable.
The convening organization and its clinical leads, with patients where the group chooses. The protocol names the questions and Attributes, and its version history travels with the dataset, so a later committee can see what was asked when each Case was enrolled.
Clinical leads to set the protocol, which RegenMed drafts with AI-assisted research for them to finalize, and support in recruiting members. No IT infrastructure is required.
Licensed datasets are de-identified under HIPAA, and each patient’s consent terms stay attached to the data. Members are paid only by the volume and completeness of their data, never by product or referral.